Navigation Links
Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
Date:5/11/2012

/#!documentDetail;D=FDA-2011-D-0618-0025">http://www.regulations.gov/#!documentDetail;D=FDA-2011-D-0618-0025.  The deadline for submitting written comments following the hearing is May 25, 2012.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com. Follow us on www.twitter.com/amgen.

Forward-Looking Statements

This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2011, and in our periodic reports on Form 10-Q and Form 8-K.  Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. 

No forward-looking statement can be guaranteed and actual results may differ materially from those we project.  The Company's results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sa
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amgen to Present at the Baird Growth Stock Conference
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
4. Amgen Announces Webcast of 2012 First Quarter Financial Results
5. UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
6. Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc.
7. Schwartz Center Receives $500,000 Grant from the Amgen Foundation
8. Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference
9. Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Micromet
10. Amgens Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33
11. Amgen Announces Final Results of Its Tender Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Nov. 24, 2014  AiCure, an artificial intelligence ... to monitor medication ingestion, has announced the start ... intervene with patients receiving medication as maintenance therapy ... from prescription opiates have quadrupled in the last ... year than heroin, cocaine and benzodiazepines combined. Overall, ...
(Date:11/24/2014)... 2014  GlySens Incorporated announced today that it has ... the National Institute of Diabetes and Digestive and Kidney ... Health (NIH).  The grant is intended to support human ... term implantable glucose monitoring system.  Final preparations for launch ... to begin before the end of 2014. ...
(Date:11/24/2014)... CLEVELAND , 24 novembre 2014 /PRNewswire/ ... la sua tecnologia sarà esposta durante l,apertura ... di simulazione d,Europa, ossia la Fondazione IRCCS ... denominati SuRgical Planner (SRP) (strumento di pianificazione ... (piattaforma di navigazione chirurgica avanzata) saranno presentati ...
Breaking Medicine Technology:Can artificial intelligence solve the $55 billion problem of opioid abuse? 2GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 2La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 3La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 4
(Date:11/26/2014)... November 26, 2014 The family foundation ... to the Mesothelioma Applied Research Foundation (Meso Foundation), half ... Foundation’s Patient Travel Grant Program . The focus ... to create grant partnerships with organizations that can generate ... Mr. Schulze is the founder and chairman emeritus of ...
(Date:11/26/2014)... The American Anthropological Association (AAA) has ... of meetings and conferences. Suvarnakar will be responsible ... and conferences. , “I am pleased to ... Executive Director Ed Liebow. “She brings the Association ... was recognized in January as the 2013 Professional ...
(Date:11/26/2014)... For its December issue , ... Report on Blue Cross and Blue Shield Plans* interviewed ... varied strategies the two Blues plans are implementing in ... for sleep apnea, ranging from brick-and-mortar retail stores to ... to increased rates of a variety of serious disorders, ...
(Date:11/26/2014)... 2014 GI for Life announced today, ... in prices of their popular nutritional supplements: ColoVite ... . Discounts of 40% will be offered for ... Life’s proprietary ColoVite supplement is a scientifically formulated vitamin ... health. One easy-to-take colon vitamin with ALL the nutrients ...
(Date:11/26/2014)... 2014 Anthropologists have identified concrete ... and stopping Ebola, improve international support, and pave ... in West Africa. , The report, “Strengthening ... Anthropologists Offer Insights,” will be made public during ... Association (AAA), Fri., Dec. 5, 11 a.m., at ...
Breaking Medicine News(10 mins):Health News:Best Buy Founder’s Family Foundation Donates $100,000 to Organization Fighting Deadly Cancer 2Health News:Best Buy Founder’s Family Foundation Donates $100,000 to Organization Fighting Deadly Cancer 3Health News:American Anthropological Association Appoints New Director of Meetings and Conferences: Ushma Suvarnakar 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 3Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3
... blood test for the efficient and swift detection of ... Medical Research Council National Institute for Medical Research// team ... further explained that the test watches out for biomarkers ... that is used for testing TB is for looking ...
... to the latest study by the Mayo clinic, injecting an ... biopsy.// ,The new study that is being presented ... of the American Urological Association, in San Diego, had found ... level of pain during their biopsy. It was explained that ...
... of Texas, Ann Richards marks the rapid increase in esophageal cancer ... diagnosed with esophageal cancer.// Only 16 % or around 2,200, of ... survive in 5 years. ,There has been a 6-fold annual ... 20 years, according to experts. Rise in obesity cases has been ...
... in the Friday’s issue of the British Medical Journal, calcium supplements ... later years.// ,According to the research, 90% of the ... Hence, it is expected that enhancing bone mass at an early ... ,The results of 19 studies, on about 2,900 kids ...
... drug that is being developed for multiple sclerosis might prove ... the experimental drug fingolimod might be effective in helping patients ... study that if in the larger and detailed studies could ... it could offer patients with MS the first effective treatment ...
... exercise has the potential to reduce the risk of colon ... US researchers says. //Lead researcher Dr. Anne McTiernan of Seattle’s ... women aged 40-75 years. ,WebMD reports that half the ... Neither group had any change in their diets. Men who ...
Cached Medicine News:Health News:Rise in Esophageal Cancer is emphasized by Richards’ deat 2Health News:An Experimental New Drug Might Be Effective In Treating MS 2